The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

RSV is a common cause of coughs and colds but can also lead to severe respiratory illness, especially in the most vulnerable.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Almost all children will get RSV during their first two years, but each year up to 80,000 children are hospitalized due to it. Now, a new FDA approved vaccine can protect your baby—even before the ...

It’s time for the provincial government to stop dragging its heels on paying for a pair of injections that can protect the ...

The NSW government will spend $16m for a free vaccination scheme to combat respiratory syncytial virus in babies, starting ...

RSV symptoms include cough, fever, running nose, irritability, reduced activity, and pauses in breathing. Severe cases can ...

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-;which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The federal government will place RSV vaccines on the national immunisation program, as 12,000 babies are hospitalised with ...